Miss Yee Wen Kong
Senior Research Coordinator
Department of Medicine
29 Scholarly works
2 Projects
HIGHLIGHTS
2026
Journal article
Survey of glucose levels in adults with T1DM attending clinic using automated insulin delivery (AID) devices compared with manual insulin delivery
DOI: 10.1016/j.diabres.2026.1131362026
Journal article
Ketone Profiles in Community-Dwelling Adults with Type 1 Diabetes Using Continuous Ketone Monitoring.
DOI: 10.1177/152091562614201862026
Journal article
Feasibility study of a combined insulin-delivery and glucose sensor system worn over 7 days in persons with type 1 diabetes
DOI: 10.1111/dom.703312026
Journal article
First in Human Feasibility Study of an Insulin Patch Pump Combined With CGM-Insulin Delivery Cannula
DOI: 10.1177/193229682614364122025
Research grants (international)
Continuous Ketone Monitoring for the Safe Use of Sodium-Glucose Cotransporter-2 Inhibitors in Type 1 Diabetes
2025
Journal article
Revisiting the benefits vs risk profile of sodium-glucose co-transporter inhibitor use in type 1 diabetes. Part B: Risks of sodium-glucose co-transporter inhibitor use in type 1 diabetes and ketoacidosis risk mitigation strategies
DOI: 10.1016/j.diabres.2025.1122842025
Research grants (other domestic)
Treatment Satisfaction With Omnipod DASH System Is Increased for Australian Adults With Type 1 Diabetes Using Either Multiple Daily Injections or Tubed Insulin Pump Therapy
RECENT SCHOLARLY WORKS
2025
Journal article
Revisiting the benefits vs risk profile of sodium-glucose co-transporter inhibitor use in type 1 diabetes Part A: Benefits of sodium-glucose co-transporter inhibitor use in type 1 diabetes
DOI: 10.1016/j.diabres.2025.1122782025
Journal article
573-P: Pre-exercise Whey Protein Ingestion to Mitigate Exercise-Induced Hypoglycemia in Adults with Type 1 Diabetes
DOI: 10.2337/db25-573-p2025
Journal article
598-P: The Glycemic Impact of Whey Protein Ingestion in Adults with Type 1 Diabetes
DOI: 10.2337/db25-598-p2025
Journal article
1003-P: Ketone Profiles in Free-living People with Type 1 Diabetes Using Continuous Ketone Monitoring
DOI: 10.2337/db25-1003-p2025
Journal article
Rationale and design of a randomised phase II multicentre crossover trial investigating a sodium-glucose co-transporter 2 inhibitor, dapagliflozin, combined with a novel continuous ketone monitor in adults with type 1 diabetes to reduce the risk of diabetic ketoacidosis: the PARTNER study
DOI: 10.1136/bmjopen-2024-098457